These cell line-specific differences of BCR/Abl protein suppression kinetics, when evaluated together with those relative to the reduction of CML cell number (Figure 1), seem to indicate that this reduction followed BCR/Abl suppression, in keeping with previous conclusions [12]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.